CompletedNCT00358306
The Role of Endothelium Dysfunction in Progression of CKD (Chronic Kidney Disease) After AKI (Acute Kidney Injury)
Studying Hemolytic uremic syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Alabama at Birmingham
- Principal Investigator
- David Askenazi, MDUAB Pediatric Nephrology
- Enrollment
- 36 enrolled
- Eligibility
- 2-20 years · All sexes
- Timeline
- 2008 – 2009
Study locations (1)
- University Of Alabama, Birmingham, Alabama, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00358306 on ClinicalTrials.govOther trials for Hemolytic uremic syndrome
Additional recruiting or active studies for the same condition.